Complications of Radiation Therapy for Head and Neck Cancers
Authors:
- Alison M. Rose-PedARAlison M. Rose-Ped
- Lisa A. BellmLBLisa A. Bellm
- Joel B. EpsteinJEJoel B. Epstein
- Andy TrottiATAndy Trotti
- Clement GwedeCGClement Gwede
- Henry J. FuchsHFHenry J. Fuchs
Top Cited Papers
- 1 December 2002
- journal article
- Published by Wolters Kluwer Health in Cancer Nursing
- Vol. 25 (6) , 461-467
Abstract
Newer treatments for head and neck cancers, including altered fractionation and the use of concomitant radiotherapy and chemotherapy, may provide better local-regional tumor control rates; however, patients may experience more frequent and more severe acute toxicities that result in considerable suffering. Through this study, we sought a better understanding of patients' experiences when undergoing radiotherapy. Personal interviews were conducted with 33 individuals who had received radiotherapy for head and neck cancers. These individuals described their treatment experiences and identified the most troublesome and debilitating side effects of radiotherapy. Overall, lethargy and weakness, dry mouth, mouth sores and pain, taste changes, and sore throat were the most frequently reported troublesome or debilitating side effects. The single most debilitating side effect was oropharyngeal mucositis that was characterized by patients as sore throat, and mouth sores and pain; both negatively affected the patient's ability to eat and drink, causing many patients to experience significant weight loss. Trends toward more aggressive management of head and neck cancers underscore the need for new and effective therapies for oropharyngeal mucositis occurring in patients receiving radiotherapy.Keywords
This publication has 31 references indexed in Scilit:
- A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Toxicity in head and neck cancer: a review of trends and issuesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?Radiotherapy and Oncology, 1999
- The National Cancer Data Base Report on Cancer of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 1998
- Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck CancerNew England Journal of Medicine, 1998
- Treatment-induced mucositis: an old problem with new remediesBritish Journal of Cancer, 1998
- The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trialBritish Journal of Cancer, 1996
- Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.Journal of Clinical Oncology, 1995
- Late effects of radiation therapy in the head and neck regionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts new evidence for accelerated proliferation from radiation therapy oncology group protocol 8313Cancer, 1992